HAP’s Achievement Award Spotlight: Mercy Philadelphia Hospital
August 08, 2019
Pharmacists play a significant and critical role in providing Pennsylvanians with consistently exceptional care. Mercy Philadelphia Hospital is making award-winning progress with their pharmacy initiatives.
Mercy Philadelphia Hospital was awarded HAP’s 2019 In Safe Hands award with its Pharmacist-driven Vancomycin Monitoring Initiative.
The goal is to implement pharmacist-driven monitoring and dosage recommendations to reduce the number of patients experiencing toxicity in the kidneys resulting from the administration of the antibiotic vancomycin.
The rollout of this pharmacist-driven initiative included:
- In-service education to all pharmacists about vancomycin therapy dosing and monitoring
- Updates to the hospital-wide empiric dosing protocol
- Dedication of time for the monitoring process as part of the daily pharmacist workflow and schedule
- On-going clinical support for pharmacists
The results included data that suggest an encouraging downward trend in kidney toxicity after instituting the monitoring initiative. Specifically:
- An increase in the percentage of patients who had vancomycin levels monitored
- A significant rise in the percentage of patients reaching target vancomycin levels (16 percent pre-monitoring compared to 60.3 percent post)
- A reduction in the percentage of patients showing increased kidney toxicity (11 percent pre-monitoring compared to 5.6 percent post)
Congratulations to Mercy Philadelphia Hospital for reducing the rate of kidney toxicity in patients and for winning a 2019 HAP Achievement Award. Learn more about this effort as well as other 2019 award-winning programs at HAP’s website.
Questions about the HAP Achievement Awards may be directed to HAP Member Services at (717) 561-5359.